Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Trial of Ciclesonide to Assess The Antiviral Effect for Adults With Mild-to-moderate COVID-19

NCT04330586 is registered in ClinicalTrials.gov with Korea University Guro Hospital as lead sponsor.

NCT NCT04330586
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04330586 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Trial of Ciclesonide to Assess The Antiviral Effect for Adults With Mild-to-moderate COVID-19
Lead sponsor
Korea University Guro Hospital
Phase
Phase 2
Overall status
Completed
Start date
April 1, 2020
Completion date
March 31, 2021
Enrollment
68 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19